pharmaceutical brand performance

The window between Phase 3 and six months after drug product launch marks a pivotal time for pharmaceutical and biotechnology companies’ commercial efforts.  As products move through the pipeline, companies shift from market preparatory activities — such as...

As the year comes to a close, Cutting Edge Information is taking a look at the best and worst brand launches in the US over the past year. The line between a massively successful launch and a potentially disastrous one is razor thin. With that a mind, we've put...

Today pharmaceutical brand commercialization efforts begin earlier and earlier. Some companies even begin certain activities as early as pre-clinical work in support of particularly promising products. The key time period for pharmaceutical brands’ marketing...

Saying that patient adherence is straightforward is like saying the only thing required to compete at the Olympics is a plane ticket. It’s simply not true. Fostering long-term patient adherence goes beyond the scope of simply getting patients to take their...

Commercialization teams face tremendous challenges as they bring new pharmaceutical brands to market. Many of the decisions these individuals make ultimately determine a brand's success or failure. With this great weight on their shoulders, commercialization teams...

By Michelle Vitko, Senior Research Analyst In an earlier blog post, I discussed the cost of patient non-adherence -- poorer health outcomes for patients and billions of dollars in lost product revenue. Low adherence rates have been a problem for a...

By Michelle Vitko, Research Analyst Drug companies are increasingly building centralized Patient Adherence teams, as revealed in our latest study on patient adherence. This is a recent development, with most companies reaching the decision to create...

By Shaylyn Pike,Senior Research Analyst Once upon a time, a brand team's quest ended at marketing approval; revenues would take care of themselves. Fast forward 20 years, and the industry faces a much more challenging road to brand success. Receiving...

Benchmarking study results show the budget allocations and ROI for pharmaceutical brands' marketing programs   Provider support programs – initiatives implemented by drug companies to assist physicians in reimbursement for patient therapies – drive 26...

New Report Analyzes Return-on-Investment for Various Drug Marketing Activities 'Provider support' and other physician assistance strategies show some of the strongest return-on-investment among pharmaceutical marketing activities.  These activities and programs...